A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus
Enrolling
The purpose of this study is to evaluate the effect of a single dose of ALN-4324 on whole-body insulin sensitivity in participants with T2DM
Trial at a Glance
- Trial ID
- ALN-4324-002
- Condition
- Type 2 Diabetes Mellitus (T2DM)
- Drug/Treatment
- Placebo, ALN-4324
- Does this trial use a placebo?
- Yes
- Trial Type
- Interventional
- Number of Participants
- 40 participants
- Trial dates
- 2026-01-15 - 2027-05-28
For more information:NCT07465224
Who can participate?
AGE
18 to 65 Years
SEX
All
ACCEPTS HEALTHY VOLUNTEERS?
No
Inquire about a clinical trial
Contact Alnylam directly with any questions about our clinical trials.
Inquire about a clinical trial
Contact Alnylam directly with any questions
about our clinical trials.
about our clinical trials.
